Spruce Biosciences Q1 EPS $(0.28) Beats $(0.29) Estimate, Sales $2.02M Beat $1.16M Estimate

Spruce Biosciences (NASDAQ:SPRB) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.29) by 3.45 percent. This is a 30 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $2.02 million which beat the analyst consensus estimate of $1.16 million by 74.14 percent. This is a 2.85 percent increase over sales of $1.96 million the same period last year.